Ann Pediatr Endocrinol Metab.  2013 Sep;18(3):148-151. 10.6065/apem.2013.18.3.148.

Insulin pump therapy in transient neonatal diabetes mellitus

• Park JH
• Kang JH
• Lee KH
• Kim NH
• Yoo HW
• Lee DY
• Yoo EG

• KMID: 2266367
• DOI: http://doi.org/10.6065/apem.2013.18.3.148

Abstract

Neonatal diabetes mellitus (NDM) is a rare disease requiring insulin treatment. Its treatment is primarily focused on maintaining adequate glycemic control and avoiding hypoglycemia. Although insulin pump therapy is frequently administered to adults and children, there is no consensus on the use of insulin pumps in NDM. A 10 day-old female infant was referred to us with intrauterine growth retardation and poor weight gain. Hyperglycemia was noted, and continuous intravenous insulin infusion was initiated. However, the patient's serum glucose levels fluctuated widely, and maintaining the intravenous route became difficult within the following weeks. Continuous subcutaneous insulin infusion with an insulin pump was introduced on the twenty-fifth day of life, and good glycemic control was achieved without any notable adverse effects including hypoglycemia. We suggest that the insulin pump is a safe and effective mode for treating NDM and its early adoption may shorten the length of hospital stays in patients with NDM.

Keyword

Diabetes mellitus; Newborn infant; Insulin infusion systems

MeSH Terms

Blood Glucose
Diabetes Mellitus*
Female
Fetal Growth Retardation
Humans
Hyperglycemia
Hypoglycemia
Infant
Infant, Newborn
Insulin Infusion Systems*
Insulin
Length of Stay
Rare Diseases
Weight Gain
Benzeneacetamides
Glucose
Insulin
Piperidones